Gastroenterology
Pilonidal Sinus
7
Pipeline Programs↗
4
Active Trials↗
1
Companies Involved↗
Pilonidal sinus is an early-stage landscape with 7 programs across 1 company. The most active players are S.L.A. Pharma AG. 4 therapies are approved.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical3
Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Analysis
Trial Status
9
clinical trials
Recruiting4 · 44%
Completed3 · 33%
Unknown status2 · 22%
Clinical Trials
Trial Activity
9 trials
The Role of Mesenchymal Stem Cell and Exosome in Treating Pilonidal Sinus Disease in Children
Recruiting·—·N/A·NCT06391307·120 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)